FAM
NVO

Fred Alger Management’s Novo Nordisk NVO Stock Holding History

Fred Alger Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$235M Buy
+4,907,570
New +$211M 0.78% 23
2024
Q4 		– Sell
-31
Closed -$3.69K – 455
2024
Q3 		$3.69K Sell
31
-54,462
-100% -$7.26M ﹤0.01% 429
2024
Q2 		$7.78M Buy
54,493
+15,129
+38% +$2M 0.04% 209
2024
Q1 		$5.05M Buy
39,364
+16,599
+73% +$1.98M 0.03% 254
2023
Q4 		$2.36M Buy
22,765
+22,733
+71,041% +$2.25M 0.01% 311
2023
Q3 		$2.91K Hold
32
– – ﹤0.01% 455
2023
Q2 		$2.59K Buy
32
+4
+14% +$327 ﹤0.01% 508
2023
Q1 		$2.23K Buy
+28
New +$1.99K ﹤0.01% 506
2020
Q4 		– Sell
-53,598
Closed -$1.86M – 493
2020
Q3 		$1.86M Sell
53,598
-12,402
-19% -$413K 0.01% 307
2020
Q2 		$2.16M Buy
66,000
+6,000
+10% +$191K 0.01% 301
2020
Q1 		$1.81M Buy
+60,000
New +$1.79M 0.01% 284
2019
Q2 		– Sell
-28,000
Closed -$732K – 543
2019
Q1 		$732K Buy
+28,000
New +$688K ﹤0.01% 354
2018
Q4 		– Sell
-90,000
Closed -$2.12M – 557
2018
Q3 		$2.12M Hold
90,000
– – 0.01% 280
2018
Q2 		$2.08M Buy
90,000
+2,000
+2% +$47.5K 0.01% 279
2018
Q1 		$2.17M Buy
88,000
+8,000
+10% +$210K 0.01% 288
2017
Q4 		$2.15M Buy
80,000
+4,000
+5% +$102K 0.01% 284
2017
Q3 		$1.83M Buy
76,000
+24,000
+46% +$542K 0.01% 286
2017
Q2 		$1.11M Buy
+52,000
New +$1.05M 0.01% 329
2016
Q4 		– Sell
-34,000
Closed -$707K – 509
2016
Q3 		$707K Sell
34,000
-1,700
-5% -$42.1K ﹤0.01% 329
2016
Q2 		$960K Buy
35,700
+12,100
+51% +$332K 0.01% 332
2016
Q1 		$639K Sell
23,600
-48,800
-67% -$1.31M ﹤0.01% 400
2015
Q4 		$2.1M Sell
72,400
-17,000
-19% -$471K 0.01% 329
2015
Q3 		$2.42M Hold
89,400
– – 0.01% 334
2015
Q2 		$2.45M Buy
+89,400
New +$2.51M 0.01% 372

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Fred Alger Management's NVO Position: Q2 2026 in Review

Fred Alger Management opened a new position in Novo Nordisk (NVO) in Q2 2026: 4,907,570 shares worth $235M. The stake represents 0.78% of the portfolio and ranks #23 among its holdings. This is a return to the name: Fred Alger Management previously reported a position in NVO as recently as Q3 2024.

Fred Alger Management first reported a position in NVO in Q2 2015 and has held it in 24 quarters since. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Fred Alger Management held 4,907,570 shares of Novo Nordisk worth $235M as of Q2 2026.
  • Novo Nordisk was a new Fred Alger Management position in Q2 2026.
  • Novo Nordisk made up 0.78% of Fred Alger Management's portfolio in Q2 2026, its #23 holding.
  • Fred Alger Management first reported a position in Novo Nordisk in Q2 2015 and has held it in 24 quarters since.
  • 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Fred Alger Management's 13F filing for Q2 2026, filed 14 Aug 2026.